Interferon-γ-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C.
about
Vitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirinIFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapiesInterferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissivenessEndogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome.Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infectionElevated interferon-stimulated gene transcription in peripheral blood mononuclear cells occurs in patients infected with genotype 1 but not genotype 3 hepatitis C virus.Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy.Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibodyActivation and evasion of antiviral innate immunity by hepatitis C virus.Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections.Recent advances in the anti-HCV mechanisms of interferon.Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus.Viral genotype correlates with distinct liver gene transcription signatures in chronic hepatitis C virus infection.Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes.Between Scylla and Charybdis: the role of the human immune system in the pathogenesis of hepatitis C.STAT4-associated natural killer cell tolerance following liver transplantation.Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liverAcute hepatitis C: management in the rapidly evolving world of HCV.The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections.Acetaldehyde Disrupts Interferon Alpha Signaling in Hepatitis C Virus-Infected Liver Cells by Up-Regulating USP18.miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis.High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver disease.Interferon-Mediated Cytokine Induction Determines Sustained Virus Control in Chronic Hepatitis C Virus Infection.Protease inhibitors partially overcome the interferon nonresponse phenotype in patients with chronic hepatitis C.IFN-α-mediated Base Excision Repair Pathway Correlates with Antiviral Response Against Hepatitis B Virus Infection.25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end.Interferon-lambda polymorphisms and hepatitis C virus clearance revisited.Impact of IFNL4 genotype on Interferon-stimulated Gene Expression during DAA therapy for Hepatitis C.A polymorphic residue that attenuates the antiviral potential of interferon lambda 4 in hominid lineagesLongitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance
P2860
Q26784321-279BCD38-B7B8-4CFE-8D79-2045F99FAF8CQ33569876-27EDF932-91E9-4C09-A373-B5537521A7E3Q33922537-E24D3FA0-6315-45DC-B76E-090BB71171A6Q33944295-9FB03C72-C58C-41C1-8F8E-CC464F4AF047Q35053399-43FC375A-9027-43C3-984E-A6F574AB044FQ35535783-0691B333-63A0-46F2-92B6-4F476EC03A43Q35563500-32C7954A-6AC5-4A18-B08E-A99A5A688442Q35602284-2FFACA2B-A3F8-4D53-9A5C-F25DD852A5C2Q35606341-CD745F95-2105-47B7-804F-F7AE0A2831C4Q36073739-D03C80D9-07DB-4761-B09D-77D8F83AA619Q36237584-C70B26E0-971D-48F6-B767-C4872DCE31FCQ36295405-34778737-8556-4A21-9509-1247FDCA5376Q37105208-F28CB2D0-C13F-4D87-88CB-103DF068E68FQ37188844-ADC3CB64-9C9F-4B4F-810C-7810B931ED9EQ37358617-7AFAC461-622F-40F4-A392-D52335D50EA1Q37617088-227BA968-8F2A-4276-9F25-89130168D318Q37684887-3170DA67-ED80-4D36-8B57-261873CCF9BDQ38183312-04A8FA0A-2C60-4BA9-A220-77D1DDDFE3F9Q38514365-77D8C781-3C00-42CA-954B-E9D79B9392B9Q38739880-1CF6FCD0-9973-4591-AC6F-FD45EBCC2E1CQ38979938-7EE019D0-6C63-4546-8F78-535A4EBD8B62Q39483634-DD5D6CDD-93BD-4881-8293-38564B8B4444Q40936303-DE281189-6626-4620-A12D-3E5146B97764Q41016420-B835A2C8-B00E-4B9F-A217-225BF058BEDBQ41923245-F52F0556-C6F6-4B4C-88B9-52AC4CE0DD0EQ42992965-6B6D8A9B-F634-4B98-8620-D08BAD7D82F4Q45351788-3BB184F0-8DEB-46EF-BFAF-666AEAAA79CAQ52657880-7845C4C1-6DBB-4E38-A800-80FCD4299678Q57281964-B6890067-D5CF-4724-BA5B-FE81C77C80F7Q58730590-C4206F40-462D-4180-BF33-9B972B346D07
P2860
Interferon-γ-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Interferon-γ-stimulated genes, ...... tients with acute hepatitis C.
@en
Interferon-γ-stimulated genes, ...... tients with acute hepatitis C.
@nl
type
label
Interferon-γ-stimulated genes, ...... tients with acute hepatitis C.
@en
Interferon-γ-stimulated genes, ...... tients with acute hepatitis C.
@nl
prefLabel
Interferon-γ-stimulated genes, ...... tients with acute hepatitis C.
@en
Interferon-γ-stimulated genes, ...... tients with acute hepatitis C.
@nl
P2093
P50
P1433
P1476
Interferon-γ-stimulated genes, ...... tients with acute hepatitis C.
@en
P2093
Francois H T Duong
Franzisca Merkofer
Luigi Terracciano
Magdalena Filipowicz
Thomas F Baumert
Zuzanna Makowska
P304
777-786.e6
P356
10.1053/J.GASTRO.2012.05.044
P407
P577
2012-06-04T00:00:00Z